Aindro Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 16.55 Cr
- Paid Up Capital ₹ 2.93 Cr
- Company Age 23 Year, 7 Months
- Last Filing with ROC 31 Mar 2019
- Satisfied Charges ₹ 37.15 Cr
- Revenue Growth 791.39%
- Profit Growth 305.00%
- Ebitda 83.18%
- Net Worth 18.96%
- Total Assets 26.77%
About Aindro Pharmaceuticals
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24231TN2001PTC047374
- Company No.
047374
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jul 2001
- Date of AGM
28 May 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Aindro Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sudhakar Natarajan  | Director | 04-Jul-2001 | Current |
| Bhuvana | Director | 02-Jan-2003 | Current |
Financial Performance of Aindro Pharmaceuticals.
Aindro Pharmaceuticals Private Limited, for the financial year ended 2016, experienced significant growth in revenue, with a 791.39% increase. The company also saw a substantial improvement in profitability, with a 305% increase in profit. The company's net worth Soared by an impressive increase of 18.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aindro Pharmaceuticals?
In 2017, Aindro Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Colors Condominium Private LimitedSudhakar Natarajan and Bhuvana are mutual person
Charges (Loans)
₹0
₹37.15 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 27.25 Cr
- Union Bank Of India : 9.90 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 May 2007 | State Bank Of India | ₹27.25 Cr | Satisfied |
| 31 Jul 2004 | Union Bank Of India | ₹9.90 Cr | Satisfied |
How Many Employees Work at Aindro Pharmaceuticals?
Unlock and access historical data on people associated with Aindro Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aindro Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aindro Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
